Related Experiment Videos
Autologous graft-versus-host disease
1Johns Hopkins Oncology Center, Baltimore, MD 21287, USA.
Medical Oncology (Northwood, London, England)
|September 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The incidence of arthrogenic muscle inhibition in acute knee injuries: a prospective cohort study in a tertiary acute knee unit.
Asia-Pacific journal of sports medicine, arthroscopy, rehabilitation and technology·2025
Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
Breast cancer research and treatment·2021
Low loss (Al)GaAs on an insulator waveguide platform.
Optics letters·2019
DLBCL-microenvironment interactions: cytokine profiling and ECM-mediated ibrutinib resistance in a 3D bone-based model.
Medical oncology (Northwood, London, England)·2026
Enhanced anti-tumor effects of Imatinib and immune checkpoint inhibitors on gastrointestinal stromal tumor cells (GISTs): insights from monoculture and 3D co-culture models.
Medical oncology (Northwood, London, England)·2026
Phytochemicals remodel antitumor immunity via the "microbiota-metabolite-receptor" axis: focus on colorectal cancer and immunotherapy.
Medical oncology (Northwood, London, England)·2026
Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review.
Medical oncology (Northwood, London, England)·2026
IFITM3 promotes an M2-like tumor-supportive microenvironment in acute myeloid leukemia.
Medical oncology (Northwood, London, England)·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026